{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T23:30:51Z","timestamp":1761953451459,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1136\/ard.50.10.682","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"682-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?"],"prefix":"10.1016","volume":"50","author":[{"given":"J.T","family":"Halla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L","family":"Atchison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G","family":"Hardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"739","article-title":"Salicylates including aspirin and salfasalazine","volume-title":"Textbook of rheumatology","author":"P, Kimberly R.; H, Plotz P.","year":"1989","unstructured":"Kimberly R P, Plotz P H. Salicylates including aspirin and salfasalazine. In: Kelley W N, Harris E D, Jr, Ruddy S, Sledge C B, eds. Textbook of rheumatology. 3rd ed. Philadelphia: Saunders, 1989: 739-64.","edition":"3rd ed"},{"key":"ref_2","first-page":"507","article-title":"Aspirin and other nonsteroidal antiinflammatory drugs","volume-title":"allied conditions","author":"E, Paulus H.; E, Furst D.","year":"1989","unstructured":"Paulus H E, Furst D E. Aspirin and other nonsteroidal antiinflammatory drugs. In: McCarty D J, ed. Arthritis and allied conditions. 11th ed. Philadelphia: Lea and Febiger, 1989: 507-43.","edition":"11th ed"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.1973.03230020014004","article-title":"Tinnitus as an indicator of therapeutic serum salicylate levels","volume":"226","author":"Mongan, E.; Kelly, P.; Nies, K.; W, Porter W.; E, Paulus H.","year":"1973","unstructured":"Mongan E, Kelly P, Nies K, Porter W W, Paulus H E. Tinnitus as an indicator of therapeutic serum salicylate levels. JAMA 1973; 226: 142-5.","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.1780140412","article-title":"Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis","volume":"14","author":"E, Paulus H.; M, Siegal; E, Mongan; R, Okun; J, Calabro J.","year":"1971","unstructured":"Paulus H E, Siegal M, Mongan E, Okun R, Calabro J J. Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. Arthritis Rhewn 1971; 14: 527-32.","journal-title":"Arthritis Rhewn"},{"key":"ref_5","first-page":"342","article-title":"A strategy for reaching therapeutic salicylate levels in patients with rheumatoid arthritis using standardized dosing regimens","volume":"14","author":"E, Furst D.; K, Blocka; S, Cassell","year":"1987","unstructured":"Furst D E, Blocka K, Cassell S, et al. A strategy for reaching therapeutic salicylate levels in patients with rheumatoid arthritis using standardized dosing regimens. J7 Rhewnatol 1987; 14: 342-7."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/ard.47.2.134","article-title":"Salicylate ototoxicity in patients with rheumatoid arthritis: a controlled study","volume":"47","author":"T, Halla J.; G, Hardin J.","year":"1988","unstructured":"Halla J T, Hardin J G. Salicylate ototoxicity in patients with rheumatoid arthritis: a controlled study. Ann Rheum Dis 1988; 47: 134-7.","journal-title":"Ann Rheum Dis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajcp\/17.5_ts.415","article-title":"A rapid method for the determination of salicylates in serum or plasma","volume":"17","author":"J, Keller W.","year":"1947","unstructured":"Keller W J. A rapid method for the determination of salicylates in serum or plasma. Am J Clin Pathol 1947; 17: 415-7.","journal-title":"Am J Clin Pathol"},{"key":"ref_8","first-page":"1570","article-title":"An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen","volume":"16","author":"Lanza, F.; F, Rack M.; Doucette, M.","year":"1989","unstructured":"Lanza F, Rack M F, Doucette M, et al. An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen. J Rheunatol 1989; 16: 1570-4.","journal-title":"J Rheunatol"},{"key":"ref_9","first-page":"11","article-title":"Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study","volume":"19","author":"Roth, S.; Bennett, R.; Caldron, P.","year":"1990","unstructured":"Roth S, Bennett R, Caldron P, et al. Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study. Semin Arthritis Rhewn 1990; 19: 11-19.","journal-title":"Semin Arthritis Rhewn"},{"key":"ref_10","first-page":"3","article-title":"Rehabilitative audiology. An overview","volume-title":"audiolog in children and adults","author":"G, Alpiner J.","year":"1987","unstructured":"Alpiner J G. Rehabilitative audiology. An overview. In: Alpiner J G, McCarthy P F, eds. Rehabilitative audiolog in children and adults. 2nd ed. Baltimore: Williams and Wilkins, 1987: 3-17.","edition":"2nd ed"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/03009747209103000","article-title":"A pilot survey of hearing loss in patients with rheumatoid arthritis","volume":"1","author":"Heyworth, T.; P, Liyange S.","year":"1972","unstructured":"Heyworth T, Liyange S P. A pilot survey of hearing loss in patients with rheumatoid arthritis. Scand J Rheunatol 1972; 1: 81-3.","journal-title":"Scand J Rheunatol"},{"key":"ref_12","first-page":"22","article-title":"Tinnitus: progress and problems in research","volume":"40","author":"T, Sataloff R.","year":"1989","unstructured":"Sataloff R T. Tinnitus: progress and problems in research. Hearing Instruments 1989; 40: 22.","journal-title":"Hearing Instruments"},{"key":"ref_13","first-page":"7","article-title":"Tinnitus 1989. Current knowledge and treatment therapy","volume":"42","author":"Vernon, J.","year":"1989","unstructured":"Vernon J. Tinnitus 1989. Current knowledge and treatment therapy. The HearingJowunal 1989; 42: 7-11.","journal-title":"The HearingJowunal"},{"key":"ref_14","first-page":"339","article-title":"Compensation for hearing loss from occupational noise. Seminars in Hearing","volume":"9","author":"Melnick, W.","year":"1988","unstructured":"Melnick W. Compensation for hearing loss from occupational noise. Seminars in Hearing 1988; 9: 339-49."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724106000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724106000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.50.10.682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:23:53Z","timestamp":1737523433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724106000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["S0003496724106000"],"URL":"https:\/\/doi.org\/10.1136\/ard.50.10.682","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1991,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.50.10.682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1991 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}